{"id":2683,"date":"2019-11-04T18:30:00","date_gmt":"2019-11-04T18:30:00","guid":{"rendered":"http:\/\/staging.grindeks.eu\/grindeks-and-kalceks-will-participate-in-the-worlds-largest-pharmaceutical-exhibition-cphi-worldwide-2019\/"},"modified":"2022-07-04T18:32:58","modified_gmt":"2022-07-04T18:32:58","slug":"grindeks-and-kalceks-will-participate-in-the-worlds-largest-pharmaceutical-exhibition-cphi-worldwide-2019","status":"publish","type":"post","link":"https:\/\/grindeks.com\/lv\/grindeks-and-kalceks-will-participate-in-the-worlds-largest-pharmaceutical-exhibition-cphi-worldwide-2019\/","title":{"rendered":"Grindeks un Kalceks piedal\u012bsies starptautiskaj\u0101 farm\u0101cijas izst\u0101d\u0113 \u201eCPhI Worldwide 2019\u201d"},"content":{"rendered":"\n

No 5. l\u012bdz 7. novembrim Frankfurt\u0113 (V\u0101cij\u0101) norisin\u0101sies viens no svar\u012bg\u0101kajiem pas\u0101kumiem farm\u0101cijas nozar\u0113 \u2013 farmaceitisko produktu ra\u017eot\u0101ju un saist\u012bto nozaru izst\u0101de \u201eCPhI Worldwide 2019\u201d. Izst\u0101d\u0113 kop\u0101 ar citiem farm\u0101cijas nozares l\u012bderiem piedal\u012bsies ar\u012b AS Grindeks un AS Kalceks, tiekoties ar potenci\u0101lajiem un eso\u0161ajiem sadarb\u012bbas partneriem stend\u0101 nr. 91H40.<\/p>\n\n\n\n

Grindeks koncerna uz\u0146\u0113mumiem ir ambiciozi m\u0113r\u0137i un ilgtermi\u0146a pl\u0101ni, un dal\u012bba \u0161\u0101da l\u012bme\u0146a izst\u0101d\u0113s ir iesp\u0113ja stiprin\u0101t savu poz\u012bciju un sasniegt noteiktos m\u0113r\u0137us. Izst\u0101des laik\u0101 Grindeks iepaz\u012bstin\u0101s nozares profesion\u0101\u013cus ar koncerna gatavo z\u0101\u013cu formu un akt\u012bvo farmaceitisko vielu produktu portfeli. P\u0113d\u0113jo gadu laik\u0101 Grindeks akt\u012bvi str\u0101d\u0101 pie pied\u0101v\u0101to onkolo\u0123isko prepar\u0101tu kl\u0101sta papla\u0161in\u0101\u0161anas, un izst\u0101d\u0113 tiks prezent\u0113ti produktu portfelim nesen pievienotie prepar\u0101ti.<\/p>\n\n\n\n

Lai gan koncerna produkcija tiek eksport\u0113ta uz vair\u0101k nek\u0101 85 pasaules valst\u012bm, Grindeks pl\u0101no piesaist\u012bt jaunus izplat\u012bt\u0101jus un ra\u017eot\u0101jus ilgtermi\u0146a sadarb\u012bbai un biznesa att\u012bst\u012bbai cit\u0101s valst\u012bs, tai skait\u0101, strat\u0113\u0123iski noz\u012bm\u012bgos Eiropas Savien\u012bbas un Dienvidaustrum\u0101zijas valstu tirgos. T\u0101pat izst\u0101d\u0113 norisin\u0101sies tik\u0161an\u0101s ar eso\u0161ajiem partneriem, lai p\u0101rrun\u0101tu pla\u0161\u0101kas sadarb\u012bbas iesp\u0113jas.<\/p>\n\n\n\n

Koncerna meitasuz\u0146\u0113mums Kalceks, kas specializ\u0113jas tie\u0161i medikamentu izstr\u0101d\u0113 slimn\u012bcu segmentam, k\u0101 galveno uzdevumu izst\u0101d\u0113 ir noteicis kontaktu dibin\u0101\u0161anu ar jauniem sadarb\u012bbas partneriem valst\u012bs, kur Kalceks produkti v\u0113l nav pieejami, jo \u012bpa\u0161i Eiropas Savien\u012bbas valst\u012bs un Zieme\u013camerik\u0101. \u0160obr\u012bd uz\u0146\u0113muma produkcija tiek eksport\u0113ta uz vair\u0101k nek\u0101 50 valst\u012bm, un tuv\u0101kaj\u0101 laik\u0101 uz\u0146\u0113mums pl\u0101no papla\u0161in\u0101t partneru loku, aptverot liel\u0101ku \u0123eogr\u0101fisko ar\u0113nu.<\/p>\n\n\n\n

Kalceks jau ir ie\u0146\u0113mis stabilu vietu Latvijas farm\u0101cijas tirg\u016b, un stiprina savu poz\u012bciju ar\u012b pasaules l\u012bmen\u012b. Uz\u0146\u0113mumam ir ni\u0161as produkti, piem\u0113ram, Dexmedetomidine, Rocuronium, un ik gadu pied\u0101v\u0101to produktu kl\u0101sts tiek papildin\u0101ts ar 7-8 produktiem. Kalceks ir viens no vec\u0101kajiem farm\u0101cijas uz\u0146\u0113mumiem Baltijas valst\u012bs, kas specializ\u0113jas parenter\u0101lo z\u0101\u013cu formu ra\u017eo\u0161an\u0101.<\/p>\n\n\n\n

\"\"<\/figure>\n","protected":false},"excerpt":{"rendered":"

No 5. l\u012bdz 7. novembrim Frankfurt\u0113 (V\u0101cij\u0101) norisin\u0101sies viens no svar\u012bg\u0101kajiem pas\u0101kumiem farm\u0101cijas nozar\u0113 \u2013 farmaceitisko produktu ra\u017eot\u0101ju un saist\u012bto nozaru izst\u0101de \u201eCPhI Worldwide 2019\u201d….<\/p>\n","protected":false},"author":3,"featured_media":2680,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-2683","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jaunums"],"acf":[],"_links":{"self":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/2683","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/comments?post=2683"}],"version-history":[{"count":0,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/2683\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media\/2680"}],"wp:attachment":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media?parent=2683"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/categories?post=2683"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/tags?post=2683"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}